- Home
- CURR vs VANI Comparison
CURR vs VANI Comparison
Compare CURR & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURR | VANI |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.6M | 91.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CURR | VANI |
|---|---|---|
| Price | $1.46 | $1.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | 224.6K | ★ 436.7K |
| Earning Date | 11-01-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,227,053.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.33 | $0.91 |
| 52 Week High | $4.68 | $1.92 |
Technical Indicators
Market Signals| Indicator | CURR | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 35.89 | 51.12 |
| Support Level | $1.51 | $1.30 |
| Resistance Level | $1.64 | $1.55 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 16.22 | 48.38 |
Price Performance
Historical ComparisonAbout CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.